Welcome to the 47th ISOBM 2025 Conference

📅 October 13–16, 2025 | 📍 Murnau, Germany

A New Era of Biomarkers in Oncology

The 47th Annual Meeting of the International Society of Oncology and Biomarkers (ISOBM) will bring together leading experts in the field of oncology to explore the future of biomarker research and its clinical applications. This year’s focus includes molecular diagnostics, disruptive technologies, and artificial intelligence, shaping a ‘New Era of Biomarkers in Oncology’ to advance diagnosis, therapy monitoring, and patient care throughout the course of disease.

We expect more than 300 participants, including renowned scientists, experienced and early career researchers, medical clinicians, laboratory physicians, data scientists and technology specialists from across oncology. Together, they will share experiences on groundbreaking research, new biomarker technologies, and advancements in cancer diagnostics and treatment.

"We are looking forward to an inspiring conference with many active participants as we embark together on a 'New Era of Biomarkers in Oncology'."

Prof. Stefan Holdenrieder

Conference President

✨ Conference Highlights

October 13–15: Keynote lectures, poster presentations, panel discussions, and industry networking will provide new insights, constructive discussions, and collaboration opportunities.
October 16 – Workshop Day: A dedicated day of in-depth workshops will allow participants to explore biomarker-related topics in greater detail.

Keynote Speakers

Prof. Dr. Ian A. Cree

Former Head of World Health Organisation (WHO) Classification of Tumours, International Agency for Research on Cancer, France

Keynote 1: Effective Treatment Depends on Diagnosis: Why Cancer Classification Matters

Prof. Dr. med. Alena Buyx

Professor of Ethics in Medicine and Health Technologies & Director of the Institute of History and Ethics in Medicine (IHEM), Technical University of Munich (TUM), Germany

Keynote 2: Hope or Horror: AI and Ethics in Medicine